We are live on ! Find out more

1,601 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 577 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 151 | Existing positions closed: 71

22% more funds holding in top 10

Funds holding in top 10: 6579 (+14)

18% more repeat investments, than reductions

Existing positions increased: 680 | Existing positions reduced: 577

13% more capital invested

Capital invested by funds: $85.1B → $95.7B (+$10.7B)

4% more funds holding

Funds holding: 1,5421,601 (+59)

1.05% more ownership

Funds ownership: 78.1%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,601
Holders Change
+59
Holders Change %
+3.83%
% of All Funds
39.85%
Holding in Top 10
79
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+21.54%
% of All Funds
1.97%
New
151
Increased
680
Reduced
577
Closed
71
Calls
$1.14B
Puts
$1.7B
Net Calls
-$562M
Net Calls Change
-$95.5M
Name Holding Trade Value Shares
Change
Change in
Stake
HIM
226
Hermes Investment Management
United Kingdom
$28.2M +$227K +1,369 +0.8%
VDI
227
Vaughan David Investments
Illinois
$27.9M -$193K -1,164 -0.7%
Public Sector Pension Investment Board (PSP Investments)
228
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$27.5M +$548K +3,300 +2%
IGIM
229
I.G. Investment Management
Manitoba, Canada
$27M -$30.6M -183,956 -53%
EIM
230
ExxonMobil Investment Management
Texas
$26.8M -$1.44M -8,652 -5%
OC
231
Oppenheimer & Co
New York
$26.7M +$2.76M +16,589 +11%
PIA
232
Piedmont Investment Advisors
North Carolina
$26.3M -$7.2M -43,325 -21%
RJFSA
233
Raymond James Financial Services Advisors
Florida
$26.2M +$2.24M +13,482 +9%
BG
234
Bellevue Group
Switzerland
$25.5M +$12M +71,950 +86%
CWG
235
C WorldWide Group
Denmark
$25.4M -$1.42M -8,569 -5%
DCM
236
Donaldson Capital Management
Indiana
$25.3M +$4.98M +29,981 +24%
B
237
Barings
North Carolina
$25M +$14.3M +86,032 +129%
FAF
238
Fjarde Ap-fonden
Sweden
$24.5M -$1.88M -11,320 -7%
NMIMC
239
Northwestern Mutual Investment Management Company
Wisconsin
$24.4M +$10.5M +63,445 +74%
MWM
240
Merriman Wealth Management
Washington
$24.1M -$3.47M -20,902 -12%
QI
241
QS Investors
New York
$24.1M -$14.8M -88,951 -38%
IR
242
IAT Reinsurance
New York
$23.8M
AIA
243
Avalon Investment & Advisory
Texas
$23.4M -$1.74M -10,495 -7%
WG
244
Winton Group
United Kingdom
$23.1M +$5.59M +33,616 +31%
HPC
245
HM Payson & Co
Maine
$23.1M +$22.1M +133,036 +1,783%
Public Employees Retirement Association of Colorado
246
Public Employees Retirement Association of Colorado
Colorado
$23M -$801K -4,820 -3%
Squarepoint
247
Squarepoint
New York
$22.9M +$18.1M +108,827 +351%
DCM
248
Dupont Capital Management
Delaware
$22.9M +$11M +66,173 +91%
GF
249
Gabelli Funds
New York
$22.7M -$1.91M -11,500 -8%
URS
250
Utah Retirement Systems
Utah
$22.6M +$33.2K +200 +0.1%

AMGN Hedge Fund Activity: Q1 2017 in Review

1,601 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2017, worth a combined $95.7B — up 13% from $85.1B a quarter earlier.

Buyers outnumbered sellers: 151 funds opened new AMGN positions and 71 closed out — a net gain of 80 holders — while 680 added to existing stakes and 577 trimmed.

The largest buyer was BlackRock, adding an estimated $7.72B. The largest seller was Capital Research Global Investors, cutting an estimated $1.36B.

  • 1,601 institutional investors held Amgen (AMGN) as of Q1 2017, up from 1,542 in Q4 2016.
  • Funds reported $95.7B of Amgen stock for Q1 2017, up 13% quarter-over-quarter.
  • 151 funds opened new Amgen positions in Q1 2017 and 71 closed out, a net change of +80 holders.
  • The largest Amgen buyer in Q1 2017 was BlackRock, an estimated $7.72B added.
  • The largest Amgen seller in Q1 2017 was Capital Research Global Investors, an estimated $1.36B sold.

Based on aggregated 13F filings for Q1 2017.